Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-055068

Director sold 50,000 shares at an average $52.35 ($2,617,550)

  • Director acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Pellini Michael J Director 2020-10-14 Option exercise +50,000 $6.55 $327,500 50,000 D: show line 1 in the form
Pellini Michael J Director 2020-10-14 Sale −28,255 $51.89 $1,466,152 21,745 D: show line 2 in the form
Pellini Michael J Director 2020-10-14 Sale −21,745 $52.95 $1,151,398 0 D: show line 3 in the form
Open-market sales · 50,000 sh · avg $52.35 · $2,617,550

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Pellini Michael J Director 2020-10-14 Option exercise · Stock Option (Right to Buy) −50,000 100,000 D: show line 4 in the form
Loading xslF345X03/doc4.xml…